Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-07-22 @ 3:52 AM
Study NCT ID:
NCT05717166
Status:
RECRUITING
Last Update Posted:
2025-04-29
First Post:
2023-01-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
Sponsor:
David Palma
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ReDA 13176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None